Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-20-072467
Filing Date
2020-06-11
Accepted
2020-06-11 17:00:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 tm2022217d1_424b3.htm 424B3 150995
2 GRAPHIC tm2021170-1_s1img01.jpg GRAPHIC 5507
3 GRAPHIC tm2021170-1_s1img02.jpg GRAPHIC 31573
  Complete submission text file 0001104659-20-072467.txt   203670
Mailing Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018
Business Address 15 WEST 38TH STREET 10TH FLOOR NEW YORK NY 10018 (917) 438-4353
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-238799 | Film No.: 20957820
SIC: 2834 Pharmaceutical Preparations